共查询到20条相似文献,搜索用时 125 毫秒
1.
《生命的化学》2019,(5)
在过去的几年中,磁性纳米材料的快速发展对生物医学变革产生了巨大的影响。作为磁性纳米材料家族重要的一大分类,纳米级铁基氧化物由于其良好的生物相容性、表面易功能化、独特的磁学性质等特点,在生物医学相关领域展现出巨大的应用前景。本综述围绕磁场下铁基氧化物纳米材料的生物医学应用,介绍了近年来其在磁分离、磁性药物靶向(magnetic drug targeting, MDT)、磁共振成像(magnetic resonance imaging, MRI)、磁性粒子成像(magnetic particle imaging, MPI)、磁响应药物释放、磁流体热疗(magnetic fluid hyperthermia, MFH)等领域的研究进展,并对铁基氧化物纳米材料在生物医学领域未来的发展方向进行了展望。 相似文献
2.
异质结构纳米颗粒不仅可以同时拥有多种单组分纳米颗粒不同的性能,实现多功能化,还可能因组分间的相互耦合作用而产生单组分颗粒不具备的新性能,因而在化学化工、生物医学、能源催化等领域引起广泛关注.贵金属具有特殊的光学性质和催化活性;磁性纳米颗粒拥有优异的磁性能,因而备受研究人员关注.贵金属-磁性异质结构纳米材料集合了两种材料优异的性能,能通过不同的异质结构展现出不同的性质.本文根据异质结构的类型,将贵金属-磁性异质结构纳米材料分为核壳结构、蛋黄-壳结构和哑铃结构3种,总结了不同贵金属-磁性异质结构纳米颗粒的特性、制备方法及应用,并重点论述了其在诊疗一体化探针、多模态成像探针和刺激响应型药物载体生物医学领域上的应用. 相似文献
3.
纳米技术的兴起,对生物医学领域的变革产生了深远的影响。纳米材料是纳米技术发展的重要基础,它具有许多传统材料所不具备的独特的理化性质,因此在生物医学、传感器等重要技术领域有着广泛的应用前景。对几类常见的纳米材料包括纳米金、量子点、磁性纳米粒子、碳纳米管和硅纳米线在蛋白质、DNA、金属离子以及生物相关分子检测方面的应用进行综述。 相似文献
4.
磁性纳米粒子,是一类智能型的纳米材料,因其特有的性质,被广泛应用于生物医学领域,在肝癌的治疗方面也有大量的实验性研究和成果。研究和探索磁性纳米粒子治疗肝癌的新方法和途径,有着很大的现实意义。本文就磁性纳米粒子作用于肝癌细胞的生物学效应的研究现状和进展进行总结整理,从三个方面进行了综述:磁性纳米粒子直接作用于肝癌细胞,探索磁性纳米粒子的生物相容性、在肝癌细胞的分布方式以及磁性纳米粒子本身对肝癌细胞的生物学效应的影响;磁性纳米粒子协同外加磁场(稳恒磁场、极低频交变磁场和高频交变磁场)作用于肝癌细胞;磁性纳米粒子外加修饰(磁性白蛋白纳米颗粒、纳米磁流体、磁性脂质体等),作为药物载体作用于肝癌细胞。 相似文献
5.
磁性纳米材料,由于其独特的磁学性能、小尺寸效应,被广泛应用于生物医学领域.本文总结了磁性纳米材料的化学设计与合成、表面功能化方法,及其在核磁共振成像、磁控治疗、磁热疗和生物分离等生物医学领域的应用进展. 相似文献
6.
磁性纳米磁珠在微生物学检测中的应用 总被引:1,自引:0,他引:1
磁性纳米材料因具有磁响应性和可修饰等特点,被广泛地应用于生物技术各领域。本文介绍了磁性纳米材料的主要合成方法和表征,对其在生物医学领域的应用,特别是在微生物检测中的应用进行了综述。 相似文献
7.
8.
9.
10.
《中国科学:生命科学》2017,(5)
趋磁细菌产生的磁小体是生物膜包被的磁性纳米颗粒,具有优良的纳米磁特性;相比化学合成的磁性纳米材料,其生物来源赋予磁小体更好的生物相容性和遗传可操作性.在生物医学领域,除了用于磁热疗进行肿瘤治疗外,最近几年其作为靶向药物载体、可能参与肿瘤微环境调控的性质得到研究者的广泛关注;同时DNA重组技术的发展解决了磁小体的产率低而趋磁细菌难培养的问题.本文综述了磁小体的生物合成及其相关研究进展,并对其应用前景进行了展望. 相似文献
11.
12.
Elaheh Esmaeili Mahsa Khalili Alireza Naderi Sohi Simzar Hosseinzadeh Behnaz Taheri Masoud Soleimani 《Journal of cellular physiology》2019,234(8):12615-12624
Magnetic iron oxide nanoparticles are a well-explored class of nanomaterials known for their high magnetization and biocompatibility. They have been used in various biomedical applications such as drug delivery, biosensors, hyperthermia, and magnetic resonance imaging (MRI) contrast agent. It is necessary to surface modify the nanoparticles with a biocompatible moiety to prevent their agglomeration and enable them to target to the defined area. Dendrimers have attracted considerable attention due to their small size, monodispersed, well-defined globular shape, and a relative ease incorporation of targeting ligands. In this study, superparamagnetic iron oxide nanoparticles were synthesized via a coprecipitation method. The magnetic nanoparticles (MNPs) had been modified with (3-aminopropyl) triethoxysilane, and then polyamidoamine functionalized MNPs had been synthesized cycling. Various characterization techniques had been used to reveal the morphology, size, and structure of the nanoparticles such as scanning electron microscopy, transmission electron microscope, X-ray diffraction analysis, and vibrating sample magnetometer, Fourier-transform infrared spectroscopy and zeta potential measurements. In addition, the cytotoxicity property of G3–dendrimer functionalized MNPs were evaluated using 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide assay which confirmed the biocompatibility of the nanocomposites. Dendrimer functionalized MNPs are able to act as contrast agents for MRI and magnetic fluid hyperthermia mediators. A superior heat generation was achieved for the given concentration according to the hyperthermia results. MRI results show that the synthesized nanocomposites are a favorable option for MRI contrast agent. We believe that these dendrimer functionalized MNPs have the potential of integrating therapeutic and diagnostic functions in a single carrier. 相似文献
13.
Xiaowen Wang Youping Chen Changshuo Huang Xufei Wang Linyun Zhao Xiaodong Zhang Jintian Tang 《Bioelectromagnetics》2013,34(2):95-103
We investigated the relative contributions of temperature and a 300 kHz alternating magnetic field (AMF) on magnetic hyperthermia treatment (MHT). Our system consisted of an induction coil, which generated AMF by electric current flow, and a newly developed, temperature‐controlled circulating water‐jacketed glass bottle placed inside the coil. The AMF generator operated at a frequency of 300 kHz with variable field strength ranging from 0 to 11 mT. Four treatment conditions were employed: (A) control (37 °C, 0 mT), (B) AMF exposure (37 °C, 11 mT), (C) hyperthermia (46 °C, 0 mT), and (D) hyperthermia plus AMF exposure (46 °C, 11 mT) for 30 min. Cell viability and apoptotic death rate were estimated. The relative contributions or interactions of hyperthermia (46 °C) and AMF (11 mT) on MHT were evaluated using 2 × 2 factorial experiment analysis. Group A was statistically different (P < 0.05) from each of the other treatments. The observed effects on both cell viability and apoptotic cell death were influenced by temperature (97.36% and 92.15%, respectively), AMF (1.78% and 4.99%, respectively), and the interactions between temperature and AMF (0.25% and 2.36%, respectively). Thus, the effect of hyperthermia was significant. Also, AMF exposure itself might play a role in MHT, although these observations were made in vitro. These findings suggest a possible presence of an AMF effect during clinical magnetic hyperthermia. Bioelectromagnetics 34:95–103, 2013. © 2012 Wiley Periodicals, Inc. 相似文献
14.
Shigemitsu T Negishi T Yamazaki K Kawahara Y Haga A Kobayashi K Muramatsu K 《Bioelectromagnetics》2009,30(1):36-44
Exposure to man-made electromagnetic fields has increased over the past century. As a result of exposure to these fields, concerns have been raised regarding the relationship between electromagnetic fields and human health. Interest in the biological and health effects of intermediate frequency (IF) magnetic fields has grown recently because of the increase in public concern. In order to investigate whether IF magnetic fields have biological effects, we have developed a 20 kHz (IF) magnetic field exposure system for in vivo studies. The exposure facility was designed to study the biological effects of IF magnetic field on laboratory animals. The facility consists of a 9 m x 9 m x 5 m high room containing seven separate rooms including a 5.3 m x 4.5 m x 3 m high specific-pathogen free exposure room. The dimensions of the exposure system are 1.6 m x 1.6 m x 1.616 m high located inside this exposure room. The system is designed to provide magnetic fields up to 200 microT at 20 kHz with the uniformity within +/-5% over the space occupied by animals. After constructing the facility, performance tests were carried out. As a result, it was confirmed that our facility met requirements for evaluation of the biological effects of IF magnetic field on small animal experiments. In this paper, the design, construction, and results of evaluation of an animal exposure facility for the in vivo biological effects of an IF magnetic field are described. 相似文献
15.
16.
Various bio-medical applications of magnetic nanoparticles have been explored during the past few decades. As tools that hold great potential for advancing biological sciences, magnetic nanoparticles have been used as platform materials for enhanced magnetic resonance imaging (MRI) agents, biological separation and magnetic drug delivery systems, and magnetic hyperthermia treatment. Furthermore, approaches that integrate various imaging and bioactive moieties have been used in the design of multi-modality systems, which possess synergistically enhanced properties such as better imaging resolution and sensitivity, molecular recognition capabilities, stimulus responsive drug delivery with on-demand control, and spatio-temporally controlled cell signal activation. Below, recent studies that focus on the design and synthesis of multi-mode magnetic nanoparticles will be briefly reviewed and their potential applications in the imaging and therapy areas will be also discussed. 相似文献
17.
Normal mouse B lymphocytes were tested for the ability to cap plasma membrane antigen-antibody complexes following exposure to 2.45-GHz continuous wave (CW) microwaves at power densities up to 100 mW/cm2 (45 W/kg specific absorption rate), at 37, 41, and 42.5 degrees C. After a 30-minute treatment, the irradiated cells and the nonirradiated controls were tested for capping by the direct immunofluorescence technique. First, the cells were incubated for nine minutes at 37 degrees C with fluorescein isothiocyanate-conjugated goat antimouse immunoglobulin. After fixing and washing, the percentage of capped cells was determined under a fluorescence microscope. The results show that for the nonirradiated controls, capping is reduced from 90% at 37 degrees C, to 52% at 41 degrees C, to less than 5% for cells that were pretreated at 42.5 degrees C. There was no significant difference between the microwave-treated cells and the controls when both were maintained at the same temperature. In another experiment, there was no significant difference in the percentage of capping between controls and cells that were exposed to microwave radiation during capping, when the temperature in both preparations was kept at 38.5 degrees C. The results demonstrate that B-lymphocyte capping is sensitive to temperature in the range that is proposed for use in tumor therapy. 相似文献
18.
磁性纳米材料具有独特的磁学性质,可响应外磁场,产生力、热等效应。如在静磁场下将药物磁靶向递送至肿瘤部位;低频交变磁场下可将纳米药物主动渗透至病灶部位,实现瘤内均一分布;中频交变磁场作用下磁滞损耗产生热和增强的活性氧,用于肿瘤治疗。磁性纳米材料同时具有尺寸依赖的磁学性质以及表面多功能化等特点,可将磁靶向、分子靶向以及磁热疗联合。此外,磁性纳米材料具有磁共振成像性能以及纳米酶催化特性,使其在肿瘤诊疗一体化治疗方面获得了广泛应用。近年来,纳米给药系统不断被优化,基于磁性纳米材料的肿瘤靶向治疗也得到了长足的发展。鉴于此,本文围绕提高靶向肿瘤治疗效果,从磁靶向药物治疗、被动靶向磁热疗和主动分子靶向磁热疗、纳米酶特性以及诊疗一体化应用等几方面出发,综述了基于磁性纳米材料的肿瘤靶向治疗研究进展。 相似文献
19.
磁性纳米颗粒具有独特的磁学性质,即在外加交变磁场下因产生磁滞释放热量,使其在生物医学领域,特别是肿瘤磁热疗,获得了广泛应用.到目前为止,磁性纳米颗粒介导的磁热疗成为一种治疗癌症的有效手段,已进入临床三期实验.因此,针对磁性纳米颗粒本身,优化设计尺寸、形貌、组分和表面修饰来提高其磁热性能,进而减小临床应用中的颗粒浓度来最小化毒副作用的研究,对肿瘤治疗及生物医药研究具有十分重要的意义.本综述详述如何优化调制磁性纳米颗粒以提高其磁热性能,为高效、低毒的磁性纳米颗粒的设计提供了指导性的研究方向. 相似文献
20.
恒定磁场对苦荞种子的生物学效应 总被引:1,自引:0,他引:1
本试验用不同剂量的恒定磁场处理苦荞种子,结果表明:适宜的磁场可有效地提高苦荞种子萌发期的发芽势、发芽率,降低种子浸出液的电导率。 相似文献